Vimarsana
Biggest News Aggregation in the World

Greenwall Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greenwall Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greenwall Foundation Today - Breaking & Trending Today

Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates | Surgery | JAMA - Vimarsana News

Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates | Surgery | JAMA

This study develops and validates a multivariable prediction model to rank order adult heart transplant candidates by medical urgency.

Survey Shows Physicians Don't Understand FDA's Approval Process - Vimarsana News

Survey Shows Physicians Don't Understand FDA's Approval Process

A national survey conducted by UCSF researchers reveals that many physicians are unfamiliar with how the FDA regulates new drugs and medical devices.

Physician Survey Shows Lack of Understanding of the FDA's Approval Process - Vimarsana News

Physician Survey Shows Lack of Understanding of the FDA's Approval Process

Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impres

Physician Survey Shows Lack of Understanding of the FDA's Approval Process - Vimarsana News

Physician Survey Shows Lack of Understanding of the FDA's Approval Process

Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the i

IDEA trial: Skipping radiotherapy safe for younger postmenopausal patients with early-stage breast cancer - Vimarsana News

IDEA trial: Skipping radiotherapy safe for younger postmenopausal patients with early-stage breast cancer

Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to results from the IDEA clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.